Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751).
Metabolic hypofunction is a common finding in a number of neurodegenerative diseases, including Alzheimer's disease (AD). The strong linkage between the amyloid precursor protein (APP) and AD led us to examine whether over-expression of this protein in CNS-type cells had an effect on mitochondria. We found abnormal morphology in mitochondria of the neuroectodermal progeny of P19 cells stably transfected with human APP751. In addition, the mitochondria of APP-transfected clones had a decreased mitochondrial membrane potential. These changes were independent of Abeta toxicity and distinct from complex I inhibition. Our results have important implications for the earliest events in the pathophysiology of AD and, by extrapolation, for intervention therapies.
Grant
S M
SM
Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
Shankar
S L
SL
Chalmers-Redman
R M
RM
Tatton
W G
WG
Szyf
M
M
Cuello
A C
AC
D016564:Amyloid beta-Protein Precursor / Q000096:biosynthesis*; D000818:Animals; D006801:Humans; D008564:Membrane Potentials / Q000502:physiology; D051379:Mice; D008854:Microscopy, Electron; D008928:Mitochondria / Q000378:metabolism / Q000473:pathology*; D017599:Neuroectodermal Tumors / Q000378:metabolism / Q000473:pathology*; D010084:Oxidation-Reduction; D014407:Tumor Cells, Cultured
D016564:Amyloid beta-Protein Precursor